Evaluation of the 18F-PSMA Positron Emission Tomography (PET)/CT in Patients With Medullary Thyroid Cancer

NCT05534594 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Medullary Thyroid Cancer
Medullary Thyroid Carcinoma
Thyroid Carcinoma, Medullary
Thyroid Cancer, Medullary

Interventions

DRUG: 18F-PSMA-1007

Sponsor

University Medical Center Groningen